| Financial Year |
March 31 2023 |
| Monetary Funds |
14,768,629,473.22 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
505,244,102.68 |
| Accounts Receivable |
31,721,880,362.49 |
| Advances to Suppliers |
1,236,360,875.29 |
| Other Receivables |
5,156,026,526.64 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
4,227,491.33 |
| Dividend Receivable |
-- |
| Inventories |
18,158,459,816.85 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
2,489,228,096.70 |
| Other Current Assets |
4,106,292,922.40 |
| Total Current Assets |
97,729,283,707.39 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
35,209,828,123.78 |
| Long-term Equity Investment |
570,720,402.86 |
| Investment Properties |
488,937,034.38 |
| Fixed Assetes |
4,363,895,177.34 |
| Under-construction Projects |
314,855,468.39 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
640,854,154.16 |
| R&D expenses |
-- |
| Goodwill |
685,109.49 |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
1,701,745,772.47 |
| Other Non-Current Assets |
7,442,680,264.46 |
| Sub-Total of Non-Current Assets |
51,099,951,315.62 |
| Total Assets |
148,829,235,023.01 |
| Short-Term Loans |
12,466,938,864.29 |
| Trading Financial liabilities |
-- |
| Notes Payable |
4,373,996,296.36 |
| Accounts Payable |
33,419,328,561.82 |
| Accounts Received In Advance |
6,433,869.26 |
| Employee Compensation Payable |
243,208,259.55 |
| Taxes Payable |
980,584,726.03 |
| Interest Payable |
-- |
| Dividend Payable |
105,457,482.65 |
| Other payables |
9,562,600,622.58 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
4,362,936,482.70 |
| Other Current Liabilities |
5,750,328,434.10 |
| Sub-Total of Current Liabilities |
85,914,447,527.02 |
| Long-term Loans |
37,953,768,828.06 |
| Bonds Payable |
600,000,000.00 |
| Long-Term Accounts Payable |
93,488,705.84 |
| Special Payable |
-- |
| Estimatied Liabilities |
182,529,772.86 |
| Deferred Income Tax Liabilities |
19,726,807.05 |
| Other Non-Current Liabilities |
776,207,803.46 |
| Sub-Total of Non-Current Liabilities |
39,807,966,662.36 |
| Total Liabilities |
125,722,414,189.38 |
| Paid-In Capital(Or Share Stock) |
1,716,533,938.00 |
| Capital Surplus |
1,650,665,085.68 |
| Surplus Reserve |
571,991,375.42 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
4,911,080,699.55 |
| Minority Stockholder's Interest |
10,057,255,137.79 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
13,049,565,695.84 |
| Owner's Equity（Stockholder's Equity） |
23,106,820,833.63 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
148,829,235,023.01 |
